Skip to main content
Log in

Metabolomic Analysis of Adipose Tissue in Rats Exposed to Triptolide

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Triptolide is the main active component of Tripterygium wilfordii Hook. F., which is one of the forbidden species by the Chinese Ministry of Health. A GC–MS-based metabolomic approach was applied to estimate the adipose toxicity induced by triptolide. The metabolomic study discovered that triptolide exposure caused a remarkable increase in fatty acids. For instance, nonanoic acid, dodecanoic acid, cis-9-hexadecenoic acid, hexadecanoic acid, 9,12-octadecadienoic acid, trans-9-octadecenoic acid, octadecanoic acid, arachidonic acid, and eicosanoic acid increased from 1.03- to 10.21-fold in high-dose triptolide-exposed rats compared to the control group. In addition, l-alanine, glycine, l-valine, fumaric acid, l-proline, glucose, and l-tyrosine were observed to have a down-regulation in the adipose tissue, induced by triptolide exposure. Many metabolites in high-dose group demonstrated the noticeable alterations in adipose tissue of rats brought by triptolide exposure, although the difference between low-dose group and control group was not noted. The results illustrated not only fatty acid β-oxidation, lipid accumulation, and reduction of amino acids in the adipose tissue of SD rats because of triptolide exposure, but also that the tricarboxylic acid cycle was influenced. A metabolomic method was successful in finding latent biomarkers.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Xu XL, Shang Y, Jiang JG (2016) Plant species forbidden in health food and their toxic constituents, toxicology and detoxification. Food Funct 7:643–664

    Article  CAS  Google Scholar 

  2. Liu J, Li L, Zhou X, Chen XY, Huang HH, Zhao SB, Li XL, Zhong DF (2013) Metabolite profiling and identification of triptolide in rats. J Chromatogr B 939:51–58

    Article  CAS  Google Scholar 

  3. Klawitter M, Hakozaki M, Kobayashi H, Krupkova O, Quero L, Ospelt C, Gay S, Hausmann O, Liebscher T, Meier U (2014) Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells. Eur Spine J 23:1878–1891

    Article  Google Scholar 

  4. Geng Y, Fang MR, Wang J, Yu HY, Hu ZY, Yew DT, Chen W (2012) Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-kB and MAP kinases in lipopolysaccharide-treated PC12 Cells. Phytother Res 26:337–343

    CAS  Google Scholar 

  5. Qiu DM, Zhao GH, Aoki Y, Shi LF, Uyei A, Nazarian S, Ng JCH, Kao PN (1999) Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappa B transcriptional activation. J Biol Chem 274:13443–13450

    Article  CAS  Google Scholar 

  6. Willem VE (2009) Protective and therapeutic effect of triptolide in EAE explained by induction of major stress protein HSP70. J Neuroimmunol 217:10–11

    Article  Google Scholar 

  7. Lu H, Hachida M, Enosawa S, Li XK, Suzuki S, Koyanagi H (1999) Immunosuppressive effect of triptolide in vitro. Transplant Proc 31:2056–2057

    Article  CAS  Google Scholar 

  8. Wang W, Li XF, Sun WM, Zhang LR, Zhang M, Hong BZ, Lv GR (2012) Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression. J Cancer Res Clin Oncol 138:1597–1605

    Article  CAS  Google Scholar 

  9. Liu JJ, Shen M, Yue ZG, Yang ZF, Wang M, Li C, Xin CY, Wang YK, Mei QB, Wang ZP (2012) Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine 19:756–762

    Article  CAS  Google Scholar 

  10. Huang WW, He TT, Chai CS, Yang Y, Zheng YH, Zhou P, Qiao XX, Zhang B, Liu ZZ, Wang JR (2012) Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS One 7:e37693

    Article  CAS  Google Scholar 

  11. Liu L, Jiang ZZ, Liu J, Huang X, Wang T, Zhang Y, Zhou ZX, Guo JL, Yang LN (2010) Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. Toxicology 271:57–63

    Article  CAS  Google Scholar 

  12. Yuan ZX, Wu XJ, Mo JX, Wang YL, Xu CQ, Lim LY (2015) Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin. Eur J Pharm Biopharm 94:363–371

    Article  CAS  Google Scholar 

  13. Kong LL, Zhuang XM, Yang HY, Mei Y, Liang X, Li H (2015) Inhibition of P-glycoprotein gene expression and function enhances triptolide-induced hepatotoxicity in mice. Sci Rep 5:11747–11760

    Article  Google Scholar 

  14. Du FY, Liu T, Liu T, Wang YW, Wan YK, Xing J (2011) Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques. Rapid Commun Mass Spectrom 25:3167–3177

    Article  CAS  Google Scholar 

  15. Li W, Liu Y, He YQ, Zhang JW, Gao Y, Ge GB, Liu HX, Huo H, Liu HT, Wang LM (2008) Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes. Xenobiotica 38:1551–1565

    Article  CAS  Google Scholar 

  16. Hu CQ, Lin SH, Cai ZW (2014) Fatty acid profiles reveal toxic responses in adipose tissue of C57BL/6J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Anal Methods 6:8207–8211

    Article  CAS  Google Scholar 

  17. Patti GJ, Yanes O, Siuzdak G (2012) Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13:263–269

    Article  CAS  Google Scholar 

  18. Aa JY, Shao F, Wang GJ, Huang Q, Zha WB, Yan B, Zheng T, Liu LS, Cao B, Shi J (2011) Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide. Metabolomics 7:217–225

    Article  CAS  Google Scholar 

  19. Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabolomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161

    Article  CAS  Google Scholar 

  20. Liu X, Xue X, Gong LK, Qi XM, Wu YF, Xing GZ, Luan Y, Xiao Y, Wu XF, Li Y (2012) 1HNMR-based metabolomic analysis of triptolide-induced toxicity in liver-specific cytochrome P450 reductase knockout mice. Metabolomics 8:907–918

    Article  CAS  Google Scholar 

  21. Ma B, Qi HH, Li J, Xu H, Chi B, Zhu JW, Yu LS, An GH, Zhang Q (2015) Triptolide disrupts fatty acids and peroxisome proliferator-activated receptor (PPAR) levels in male mice testes followed by testicular injury: a GC–MS based metabolomics study. Toxicology 336:84–95

    Article  CAS  Google Scholar 

  22. Xia SG, Liu HL, Zhu H, Zhou ZM, Zhang X, Liu ML (2009) NMR-based metabonomic study on rat’s urinary metabolic response to dosage of triptolide. Chin J Chem 27:751–758

    Article  CAS  Google Scholar 

  23. Yan B, Jiye A, Wang GJ, Lu HL, Huang XP, Liu Y, Zha WB, Hao HP, Zhang Y, Liu LS (2009) Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J. Appl. Physiol 106:531–538

    Article  CAS  Google Scholar 

  24. Ma B, Zhang Q, Wang GJ, Jiye A, Wu D, Liu Y, Cao B, Liu LS, Hu YY, Wang YL (2011) GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats. Acta Pharmacol Sin 32:270–278

    Article  CAS  Google Scholar 

  25. Golay A, Munger R, Assimacopoulos-Jeannet F, Bobbioni-Harsch E, Habicht F, Felber JP (2002) Progressive defect of insulin action on glycogen synthase in obesity and diabetes. Metab Clin Exp 51:549–553

    Article  CAS  Google Scholar 

  26. Lin SH, Yang Z, Liu HD, Cai ZW (2011) Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo -p-dioxin. Mol BioSyst 7:1956–1965

    Article  CAS  Google Scholar 

  27. Bergman RN, Mittelman SD (2000) Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am J Physiol Endocrinol Metab 279:E630–E637

    Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (No. 31571940), the Project of Cultivate in Natural and Social Funding of Beijing Technology and Business University (No. 19008001272), Beijing Excellent Talents Funding for the Youth Scientist Innovation Team and Technology Funding for Selected Overseas Chinese Scholar, Ministry of Personnel of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

All institutional and national guidelines for the care and use of laboratory animals were followed.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 26 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, C., Wang, Y., Liao, Y. et al. Metabolomic Analysis of Adipose Tissue in Rats Exposed to Triptolide. Chromatographia 80, 1079–1087 (2017). https://doi.org/10.1007/s10337-017-3328-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-017-3328-9

Keywords

Navigation